Protagonist Therapeutics Inc
NASDAQ:PTGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
BRP Group Inc
NASDAQ:BWIN
|
US |
Intrinsic Value
The intrinsic value for
Protagonist Therapeutics Inc (PTGX) under the Base Case is 22.24 USD.
Compared with the current market price of 99.95 USD, the stock appears
Overvalued by 78% .
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Protagonist Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Protagonist Therapeutics Inc
Earnings Waterfall
Protagonist Therapeutics Inc
The intrinsic value for
Protagonist Therapeutics Inc (PTGX) under the Base Case is 22.24 USD.
Compared with the current market price of 99.95 USD, the stock appears Overvalued by 78% .